email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Bull Trader USA

Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.

NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck‘s stock, according to Citi.

Post a Comment